Xiangya Hospital, Central South University Affiliated
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jiang, Juan
RWNEOADJ-01, NCT06243679: The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

Active, not recruiting
N/A
100
RoW
Immunotherapy
Xiangya Hospital of Central South University
Resectable/Potentially Resectable NSCLC
09/27
12/27
NCT06503939: Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

Enrolling by invitation
N/A
600
RoW
Xiangya Hospital of Central South University
Chronic Cough
12/24
12/24
NCT06341231: Personalized Anticoagulant Therapy for Pulmonary Thromboembolism

Recruiting
N/A
4700
RoW
Xiangya Hospital of Central South University
Pulmonary Thromboembolisms, Anticoagulants; Increased
12/26
12/27

Download Options